Outlook Therapeutics, Inc. - Se (OTLKW) Financials

NASDAQ Currency in USD Disclaimer

$0.03

north_east NA Past Year
Day's range
$0.01
Day's range
$0.04

OTLKW Income statement / Annual

Last year (2023), Outlook Therapeutics, Inc. - Se's total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Outlook Therapeutics, Inc. - Se's net income was -$58.98 M. See Outlook Therapeutics, Inc. - Se,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 09/30/2023 09/30/2022 09/30/2021 09/30/2020 09/30/2019 09/30/2018 09/30/2017 09/30/2016 09/30/2015 09/30/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $8.15 M $3.09 M $3.81 M $2.98 M $5.22 M $9.05 M
Cost of Revenue $44,188.00 $204,694.00 $262,139.00 $554,069.00 $23,805.00 $18,504.00 $23,809.00 $32,763.00 $38,876.00 $14,124.00
Gross Profit -$44,188.00 -$204,694.00 -$262,139.00 -$554,069.00 $8.12 M $3.07 M $3.79 M $2.95 M $5.18 M $9.04 M
Gross Profit Ratio 0 0 0 0 1 0.99 0.99 0.99 0.99 1
Research and Development Expenses $26.45 M $42.33 M $38.96 M $26.34 M $23.81 M $18.50 M $23.81 M $32.76 M $38.88 M $14.12 M
General & Administrative Expenses $26.67 M $20.74 M $12.77 M $9.97 M $9.37 M $14.23 M $15.88 M $21.64 M $12.91 M $7.32 M
Selling & Marketing Expenses $0.00 $0.00 $279,675.00 -$1.90 M -$3.85 M -$7.25 M -$2.69 M -$2.47 M $0.00 $0.00
Selling, General & Administrative Expenses $26.67 M $20.74 M $13.05 M $8.08 M $5.52 M $6.97 M $13.19 M $19.17 M $12.91 M $7.32 M
Other Expenses $0.00 -$882,903.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $53.13 M $63.07 M $51.73 M $36.31 M $29.33 M $25.48 M $39.69 M $51.93 M $51.78 M $21.44 M
Cost And Expenses $53.13 M $63.07 M $51.73 M $36.31 M $32.69 M $28.53 M $39.69 M $54.74 M $51.78 M $21.44 M
Interest Income $1,559.75 $1,487.46 $936.13 $1,756.47 $3,466.69 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $1.56 M $1.49 M $936,000.00 $1.76 M $3.47 M $3.89 M $5.63 M $1.47 M $2.30 M $901,052.00
Depreciation & Amortization $44,188.00 $204,694.00 $262,139.00 $554,069.00 $3.36 M $3.05 M $2.69 M $2.39 M $1.82 M $878,477.00
EBITDA -$57.38 M -$62.87 M -$51.46 M -$35.76 M -$31.11 M -$26.79 M -$30.03 M -$48.95 M -$44.74 M -$11.51 M
EBITDA Ratio 0 0 0 0 -2.66 -7.25 -8.71 -16.57 -8.57 -1.27
Operating Income Ratio 0 0 0 0 -4.46 -8.24 -9.41 -17.37 -8.92 -1.37
Total Other Income/Expenses Net -$5.85 M -$2.98 M -$1.43 M -$1.67 M -$1.64 M -$4.10 M -$2.47 M -$1.85 M -$2.30 M -$901,052.00
Income Before Tax -$58.98 M -$66.05 M -$53.16 M -$38.51 M -$37.93 M -$33.74 M -$38.35 M -$53.23 M -$48.86 M -$13.29 M
Income Before Tax Ratio 0 0 0 0 -4.66 -10.93 -10.06 -17.86 -9.36 -1.47
Income Tax Expense $2,800.00 $2,800.00 $2,000.00 -$3.27 M -$3.41 M -$3.65 M $501,500.00 $103,000.00 -$190,111.00 $439,018.00
Net Income -$58.98 M -$66.05 M -$53.16 M -$35.24 M -$34.52 M -$46.11 M -$38.85 M -$53.33 M -$47.39 M -$13.73 M
Net Income Ratio 0 0 0 0 -4.24 -14.94 -10.19 -17.9 -9.08 -1.52
EPS -4.72 -6.23 -6.96 -9.71 -37.96 -50.7 -258.75 -495.71 -504.47 -155.35
EPS Diluted -4.72 -6.23 -6.96 -9.71 -37.96 -50.7 -258.54 -495.71 -504.47 -155.35
Weighted Average Shares Out $12.51 M $10.60 M $7.63 M $3.63 M $909,591.00 $909,591.00 $150,139.00 $107,581.00 $93,946.00 $88,398.00
Weighted Average Shares Out Diluted $12.51 M $10.60 M $7.63 M $3.63 M $909,591.00 $909,591.00 $150,261.00 $107,581.00 $93,946.00 $88,398.00
Link